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OBJECTIVE—Salsalate is a dimeric form of salicylic acid that
has been shown to have anti-inﬂammatory activity and to reduce
glucose levels, insulin resistance, and cytokine expression. How-
ever, the effect of salsalate on vascular injury has not been
determined. The objective of this study is to investigate the effect
of salsalate on vascular injury and repair in a rat model of carotid
artery balloon catheter injury.
RESEARCH DESIGN AND METHODS—Salsalate treatment
was started in female Zucker fatty rats (insulin resistant) 1 week
before carotid artery balloon catheter injury and continued for 21
days, at which time the animals were killed and studied.
RESULTS—Treatment with salsalate signiﬁcantly decreased the
intima-to-media ratio and upregulated the expression of aortic
endothelial nitric oxide synthase (eNOS), phosphorylated eNOS
(p-eNOS) (ser 1177), and manganese superoxide dismutase
(MnSOD) and reduced serum interleukin (IL)-6 with concomitant
downregulation of nuclear factor (NF) B subunit p65 and
vascular endothelial growth factor (VEGF) expression in the
balloon-injured carotid artery of female Zucker fatty rats.
CONCLUSIONS—The present study shows that salsalate treat-
ment decreases vascular damage caused by balloon catheter
injury in female Zucker fatty rats. The beneﬁcial effect of
salsalate on vascular injury was associated with upregulation of
eNOS, p-eNOS, and MnSOD, which reduce oxidative stress and
have anti-inﬂammatory properties, as evidenced by reduction in
serum IL-6 and the downregulation of VEGF and NFB, which
promote inﬂammation without changing glucose levels. These
results suggest that salsalate may be useful in reducing vascular
injury and restenosis following interventional revascularization
procedures. Diabetes 59:3240–3246, 2010
T
ype 2 diabetes is an important, independent risk
factor for heart disease (1), and it is reported
that cardiovascular disease (CVD) accounts for
up to 80% of excess mortality in patients with
type 2 diabetes. Further, these patients have a twofold
increased risk of death independent of other known
cardiovascular risk factors (2,3). More than 17 million
Americans suffer from either type 1 or type 2 diabetes, and
newly diagnosed cases are increasing. In addition, from an
epidemiologic view point, the prediabetic population is
considered to be the most important group, comprising
several thousand individuals (4). Insulin resistance plays a
key role in the pathogenesis of type 2 diabetes and is a
hallmark of metabolic disorders including dyslipidemias,
obesity, hypertension, and CVD (5–7). In patients with
diabetes, interventional vascular procedures such as bal-
loon angioplasty and stent placement have been shown to
result in greater restenosis rates (8). These procedures
cause mechanical injury to the artery, leading to a cascade
of cellular and inﬂammatory events. Intimal hyperplasia is
an underlying cause of restenosis and vessel narrowing;
however, the mechanisms causing intimal hyperplasia are
not well understood (9). Obesity, diabetes, and CVD have
been shown to be associated with chronic low-level vas-
cular inﬂammation (10). The potential for suppression of
inﬂammation in the treatment of these conditions is an
active area of investigation.
Salicylates are among the most commonly used nonste-
roidal anti-inﬂammatory drugs (11). The reduction of
glycosuria by high doses of sodium salicylate (5.0–7.5
g/day) was shown in diabetic patients having “the milder
form of the disease,” presumably type 2 diabetes (12–14).
In recent studies (15,16), the hypoglycemic actions of
salicylates were investigated, and the molecular target was
shown to be the IB kinase complex  (IK)/nuclear
factor (NF) B pathway. This pathway is a critical regula-
tor of proinﬂammatory signals (10).
Salsalate belongs to the drug class of salicylates and is
the dimeric form of salicylic acid (17). This compound is
known to inhibit the formation of proinﬂammatory cyto-
kines including tumor necrosis factor (TNF)-, interleukin
(IL)-6, and IL-7 (18). Salsalate is known to inhibit the
expression of vascular cell adhesion molecule-1, intercel-
lular adhesion molecule-1, and endothelin-1, which are
produced by the endothelium in response to injury.
Recent studies (19,20) have shown that increased ex-
pression of vascular endothelial growth factor (VEGF) (a
powerful mitogen for endothelial and vascular smooth
muscle cells) may lead to increased neointimal hyperpla-
sia after angioplasty. Moreover, the use of an anti-VEGF
(bevacizumab)-coated stent decreased intimal hyperplasia
postangioplasty in rabbits (21). Novotny et al. (22) have
reported that the expression and secretion of VEGF is
mediated by NFB. Based on the known inhibitory effect
of salsalate on NFB, it is possible that this agent may
decrease the expression of VEGF, leading to decreased
intimal hyperplasia after angioplasty; however, this hy-
pothesis has not yet been tested. In addition, insulin
stimulates VEGF expression, and animal models that are
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ciated with increased VEGF expression after angioplasty
(19). Salsalate may decrease inﬂammation by inhibiting
NFB and decrease insulin resistance, which, in turn, may
result in a decrease in expression of VEGF.
In view of the beneﬁcial effects of salsalate on glucose
metabolism, the NFB/IK pathway, and inﬂammation,
we investigated the effect of salsalate on the inﬂammatory
response that follows vascular injury. Additionally, as
inﬂammatory responses have been linked to the produc-
tion of reactive oxygen species (ROS) (23), we ascertained
if salsalate treatment had antioxidant effects that had a
role in the vascular recovery process. Finally, we explored
the potential effects of salsalate on VEGF expression, an
important growth factor. In the present communication,
we report the effect of salsalate on the balloon catheter–
injured carotid artery in an animal model of insulin
resistance.
RESEARCH DESIGN AND METHODS
The protocol used for animal experiments in the present study was approved
by the institutional animal care and use committee of the Tulane University
School of Medicine, New Orleans, Louisiana. Nine- to 10-week-old female
Zucker fatty rats were obtained from Harlan Sprague Dawley (Indianapolis,
IN). The Zucker fatty rats are obese with normal glucose, but they exhibit
hyperphagia, hypertriglyceridemia, hyperinsulinemia, and reduced glucagon
levels (24). This model will therefore facilitate in avoiding the confounding
effects of major changes in blood glucose concentration. In addition, insulin-
resistant models are associated with a propensity for neointimal proliferation,
an observation not seen in insulin-deﬁcient models with or without exogenous
insulin administration (9,25).
The rats were housed individually with free access to food and water and
were maintained in a temperature- and humidity-regulated room with a 12-h
light/dark cycle. After an acclimatization period, the rats were randomly
divided into a control group and a salsalate treatment group. The control
group received food ad libitum, and the animals in the experimental/salsalate
group received 300 mg/day salsalate mixed in the food given ad libitum.
Treatment with salsalate was initiated 1 week prior to balloon catheter
injury of the left carotid artery and continued for an additional 21 days after
injury. The body weight and blood glucose levels (fasting) were determined at
weekly intervals. Blood glucose levels were measured with a glucometer using
tail vein blood samples, and typically the blood sample was taken after
overnight fasting of the rats.
Balloon catheter–induced injury. After 1 week of feeding rats the salsalate-
containing diet, balloon injury was induced as previously described (25,26).
Brieﬂy, the rats were anesthetized with 5% isoﬂurane in oxygen, and the
femoral artery was approached. Using standard methods, a Maverick over-
the-wire catheter (20  2.0 mm; Boston Scientiﬁc, Natick, MA) was passed up
the aorta to the carotid artery under ﬂuoroscopic control. The balloon was
inﬂated to 4.0 atmospheres and held for exactly 20 s before partial deﬂation.
The pressure was then reduced to 2.0 atmospheres, and the balloon was
dragged to the descending aorta for denudation of the endothelium. At this
point, the catheter was completely deﬂated and the pressure made negative.
The catheter was then gently withdrawn while simultaneously tying the artery
with a sterile 7/0 silk suture. The incision was closed with Vicryl sutures, and
the animals were allowed to recover before being returned to the vivarium.
The rats were maintained on their respective diet (control or salsalate
added) for 3 weeks after the procedure and killed on day 22 after the
procedure. The animals were killed in a CO2 chamber, and a blood sample was
taken in addition to harvesting injured and contralateral carotid arteries (for
comparison), aorta, heart, and other tissues. The blood and tissue samples
were processed for biochemical and histological analysis. Both injured and
uninjured carotid arteries were processed for sectioning. The carotid artery
sections were hematoxylin and eosin (H&E) stained, and the intima-to-media
ratio (I/M) was measured at a magniﬁcation of 10. Computerized digital
microscopic software (Image-Pro Plus 4) was used to obtain intimal and
medial area measurements as previously reported (25,26).
Morphometric measurements. The carotid arteries were stored overnight in
neutral-buffered formalin (McKinney, TX) at 4.0°C for processing for dehydra-
tion. The common carotid artery segment between the carotid bifurcation and
the aortic arch was carefully separated and divided into four equal segments
for parafﬁn embedding. From these parafﬁn blocks, 6- sections were cut on
a microtome and used for staining. All four sections of the artery (individual)
were selected for measurement data and an analysis of the stained sections at
a magniﬁcation of 10. Computerized digital microscopic software (Image-
Pro Plus 4) was used to obtain measurements of the intimal and medial areas
by a previously described method (25,26). The I/M ratio was calculated for all
specimens for comparison between treatment groups.
Biochemical parameters. At the time the rats were killed, a blood sample,
both the injured and the contralateral carotid arteries, the aortic arch, and
other tissue samples were harvested. The blood and tissue samples were
processed by standard methods and appropriately stored for subsequent
biochemical analysis. The serum was used for the analysis of IL-6. Protein was
isolated from aorta for Western blot analysis of endothelial nitric oxide
synthase (eNOS), phosphorylated eNOS (p-eNOS) (ser-1177), NFB subunit
p65, and manganese superoxide dismutase (MnSOD or SOD2). Following
endothelial denudation, eNOS and p-eNOS, important regulators of vascular
homeostasis, were evaluated for alterations in endothelial function and
recovery; SOD2 was analyzed to ascertain if salsalate treatment was modu-
lating the antioxidative defense mechanism. Balloon catheter–induced endo-
thelial denudation injures the vessel evoking an inﬂammatory response.
Therefore, for evaluating the inﬂammatory status in serum from salsalate-
treated animals, IL-6 and aortic NFB subunit p65, a well-established
biomarker, were assayed (27). Serum IL-6 was analyzed by the enzyme
immunosorbent assay method using a Quantikine IL-6 immunoassay kit
(R&D Systems, Minneapolis, MN).
Immunohistochemistry for VEGF. The immunohistochemical analysis for
VEGF was carried out using previously described methods (19). Cross-
sections of formalin-ﬁxed, parafﬁn-embedded carotid arteries were used for
analysis. The carotid artery sections were obtained as described in the
morphometric analysis section. Each sample was deparafﬁnized in xylene and
gradually rehydrated using decreasing percentages of ethanol. After blocking
endogenous peroxidase with 30% H2O2 in methanol for 20 min, an antigen-
retrieval step was added by microwaving the samples in citrate buffer (pH 6.0)
for 30 min. The samples were then washed three times with PBS, followed by
incubation with Chem Mate blocking antibody solution (DAKO, Carpentaria,
CA) for 30 min. The samples were then incubated for1ha troom temperature
with murine anti-VEGF (Oncogene, San Diego, CA), diluted 1:50 in PBS. The
samples were then washed and incubated with ready-to-use DAKO EnVision
peroxidase for 30 min at room temperature. After incubation, the slides were
rinsed in PBS and exposed to stable diaminobenzidine tetrahydrochloride,
and the reaction was monitored using light microscopy. The sections were
then counterstained with Mayer hematoxylin.
For quantiﬁcation, four sections from each carotid artery were analyzed.
The images were recorded using a SPOT cooled-color digital camera linked to
a computer. Digitized software (AN@lysis) was used to measure the staining
intensity of the neointima. The total intensity of staining of all the pixels in the
neointimal area were measured and then divided by the total number of pixels
in the neointima to obtain a mean staining density value.
Western blot analysis. Aortic tissue was homogenized and incubated in a
lysis buffer. The bicinchoninic acid protein assay (Pierce, Rockford, IL) was
used to quantify protein (28). Proteins of equal quantities were electropho-
resed on 4–20% gradient gels (Jule, Milford CT). The protein was transferred
to a nitrocellulose membrane (GE Healthcare, Piscataway, NJ). The mem-
brane was blocked for1hi n5 %milk in Tris-buffered saline (TBS) with 0.1%
Tween (TBST). The membrane was then washed three times for 5 min and
incubated with primary antibodies, which were puriﬁed mouse anti-eNOS/
NOS type III (BD Transduction Laboratories), NFB p65, and MnSOD at a
dilution of 1:1,000 overnight. The membrane was washed three times with
TBST, and bound antibody was detected using anti-mouse IgG–horseradish
peroxidase (HRP) secondary antibody (Santa Cruz Biotechnology) and anti-
rabbit IgG-HRP (Santa Cruz), respectively. Lumiglo chemiluminescense (KPL,
Gaithersburg, MD) was used to detect bound protein, and the protein was
quantiﬁed using QuantityOne analysis software (Bio-Rad, Hercules, CA).
These standard methods have been routinely used by other investigators
(29,30). For the Western blot analysis of p-eNOS (ser 1177), goat polyclonal
IgG (Santa Cruz Biotechnology, Santa Cruz, CA) was diluted at 1:1,000 for
incubation overnight. The secondary antibody was donkey anti-goat IgG-HRP
obtained from Santa Cruz Biotechnology and was used at a dilution of 1:2,000.
For analysis of MnSOD, the tissue was homogenized in lysis buffer and
centrifuged at 10,000g for 10 min at 4°C. Protein concentration of these
homogenates was determined using the bicinchoninic acid method (Pierce).
Equal quantities of protein were electrophoresed on 4–20% gradient gels
(Jule). The protein was then transferred to a nitrocellulose membrane (GE
Healthcare). The membrane was blocked for1hi n5 %milk in TBST. The
membrane was washed three times for 5 min each and then incubated in
polyclonal MnSOD antibody (Cayman Chemical, Ann Arbor, MI) at a dilution
of 1: 1,000 overnight. The membrane was washed with TBS, and then bound
antibody was detected using anti-rabbit IgG-HRP secondary antibody (Santa
Cruz biotechnology) at a dilution of 1:2,000 for 30 min. For the detection and
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was used. Densitometric analysis of the autoradiographs was carried out with
QuantityOne analysis software (Bio-Rad).
Statistical analysis. Statistical analysis was performed using the Sigma Stat
(SSPS, Chicago, IL) and GraphPad software programs (GraphPad Software,
LA Jolla, CA). One-way ANOVA, unpaired t test, and all pairwise multiple
comparison procedures (Tukey test) were used. Data are reported as means 
SE. Statistical signiﬁcance was set at an  of 0.05.
RESULTS
The data on body weight gain and morphometric and
biochemical analysis of control and salsalate-treated
Zucker fatty rats are presented in Table 1. The gain in body
weight over the experimental period and fasting glucose
levels were not signiﬁcantly different; however, the I/M
ratio, serum IL-6, and the expression of eNOS, p-eNOS,
MnSOD, and NFB subunit p65 were signiﬁcantly
different.
I/M ratio. The morphometric measurement of the carotid
artery cross-sections from the balloon catheter–injured
and untreated or control and salsalate-treated groups of
rats had an I/M ratio of 0.9  0.2 vs. 0.19  0.11 (P  0.05).
Representative sections of H&E-stained carotid arteries
from uninjured (Fig. 1A), injured, and untreated/control
(Fig. 1B) rats are presented in Fig. 1. The treatment with
salsalate resulted in signiﬁcant attenuation of the hyper-
plastic response. A representative H&E-stained carotid
artery section from balloon catheter–injured and salsalate-
treated rats is shown in Fig. 1C. The quantitation of intimal
hyperplasia is shown in Fig. 1D. These results suggest that
the attenuating effect on intimal hyperplasia could be
attributed, at least in part, to treatment with salsalate.
VEGF expression. VEGF intimal staining intensity was
measured in carotid sections as described in RESEARCH
DESIGN AND METHODS. Intimal VEGF protein staining intensity
was signiﬁcantly decreased by 22% in salsalate-treated rats
(62  7) versus untreated rats (78  6). Representative
sections of immunostained carotid artery sections from
balloon catheter–injured, untreated/control (Fig. 2A), and
balloon catheter–injured and salsalate-treated (Fig. 2B)
rats are shown in Fig. 2.
Western blot analysis: eNOS, p-eNOS, and NFB p65.
The relative density units (RDUs) obtained from the
densitometric scan of the Western blots (after normal-
izing expression levels to corresponding -actin) indi-
cate a signiﬁcant increase in the expression of eNOS in
aortic arch protein samples from salsalate-treated rats
(0.15  0.07) as compared with the control group
(0.03  0.01) (P  0.05), indicating a ﬁvefold increase
(0.15/0.03) (Fig. 3). The p-eNOS expression was in-
creased in aortic arch samples from salsalate-treated
rats (2.0  0.5) compared with expression in control
rats (0.2  0.06) (P  0.005), indicating a 10-fold
increase (2.0/0.2). The ratio of p-eNOS to eNOS in the
control animals was 6-to-1 (0.2/0.03) and 13-to-1 (2.0/
0.15) in the rats treated with salsalate (Fig. 4). These
results indicate that there was a signiﬁcant increase in
the level of p-eNOS in salsalate-treated rats.
The results of Western blot analysis of the aortic arch
for NFB subunit p65 showed a signiﬁcant decrease in
expression in the salsalate-treated group (mean relative
densities of the salsalate-treated and control groups:
0.159  0.054 vs. 0.600  0.110; P  0.05). This decrease
indicates that downregulation of the NFB p65 pathway
may have a role in the beneﬁcial effect of salsalate in
attenuating the inﬂammatory response following carotid
artery balloon catheter injury (Fig. 5).
Serum IL-6. The serum IL-6 levels were assayed by
enzyme immune assay methods (per manufacturer’s in-
structions). The serum IL-6 levels were signiﬁcantly de-
creased in rats treated with salsalate versus controls (88 
1.8 vs. 99.2  2.9) and suggest that salsalate produced a
better recovery from balloon injury by inducing an anti-
inﬂammatory effect.
Western blot analysis: MnSOD. MnSOD expression was
analyzed in the aortic arch by Western blot analysis, and
there was a clear increase in the expression of this
antioxidant defense enzyme in salsalate-treated rats (mean
relative densities of the salsalate was 1.2  0.2 and control
was 0.67  0.07; P  0.05), suggesting that salsalate
therapy could reduce the expression of ROS and tissue
injury. The Western blot analysis of MnSOD is shown in
Fig. 6.
DISCUSSION
In the present study, we observed that Zucker fatty rats
pretreated with salsalate and subjected to carotid artery
injury and placed on the treatment regimen exhibited a
marked reduction in the hyperplastic vascular response
normally seen in untreated animals. Compared with the
control group, the salsalate-treated rats had I/M ratios of
0.19  0.11 vs. 0.9  0.2 (P  0.05). These rats are obese
with normal glucose levels but exhibit hyperphagia, hyper-
triglyceridemia, hyperinsulinemia, and reduced glucagon
levels (24). This model therefore allowed us to avoid the
effects of major changes in blood glucose concentration.
To study the effects of an intervention on vascular injury,
this model is advantageous, as it has a propensity for
neointimal proliferation that is not seen in insulin-deﬁcient
rats and is independent of insulin administration (9,25).
Intimal thickening in response to injury is associated
with inﬂammation and proliferation of vascular smooth
muscle cells and has been observed in diabetes and with
insulin resistance (6). Studies have shown that vascular
injury in response to balloon angioplasty and stent place-
ment results in greater restenosis rates in patients with
diabetes (8,9).
Ongoing clinical trials evaluating the effects of salsalate
treatment and the use of salsalate in the type 2 diabetes
(Targeting Inﬂammation Using Salsalate in Type 2 Diabe-
tes [TINSAL]) trial will provide further information on the
effect of salsalate (TINSAL 2009) and the metabolic syn-
TABLE 1
Biochemical and morphometric analysis of carotid artery–
injured female Zucker fatty rats treated with salsalate
Control
Salsalate
treated P
Gain in body weight over
the experimental
period 89  8 90.7  15.5 NS
Fasting blood glucose
(mg/dl) 89  6 71.4  3.5 NS
I/M ratio 0.9  0.2 0.19  0.11* *0.05
IL-6 (pg/ml) 99.2  2.9 88  1.8* *0.05
NFB p65 (RDUs) 0.6  0.1 0.16  0.05* *0.05
MnSOD (RDUs) 0.67  0.07 1.2  0.2* *0.05
eNOS (RDUs) 0.03  0.001 0.14  0.07* *0.05
p-eNOS (ser 1177)
(RDUs) 0.2  0.06 2.0  0.5† †0.005
Data are means  SE.
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nism of the beneﬁcial action of salsalate on vascular injury
may be relevant to type 2 diabetes population.
The mechanisms mediating intimal thickening that oc-
cur in response to inﬂammation are less well understood
than those originating from vascular injury. Although
controversial, a role for the NF light-chain enhancer of
activated B-cells (NFB) pathway has been suggested.
NF light-chain enhancer is known to induce the synthesis
of proinﬂammatory cytokines and chemokines (TNF-,
IL-6, IL-1, etc.) and to stimulate the recruitment of
macrophages to adipose tissue (27). The upregulation of
proinﬂammatory cytokines and chemokines (TNF-, IL-6,
IL-1, etc.) by NFB during inﬂammation has been docu-
mented (31). The effect of lowering circulating IL-6 by
salsalate, as observed in our studies, provides support for
the role of NF light-chain enhancer as well.
Although the mechanism of action of salsalate is not
well understood, it is possible that this agent suppresses
NFB via inhibition of IKK. Salsalate has been used for
decades to treat inﬂammation and has a good safety
proﬁle, including a lower bleeding risk when compared
with aspirin (17). It was reported that after administra-
tion of3go fsalsalate for 7 days, the fasting plasma
glucose concentration was signiﬁcantly decreased when
assessed by the oral glucose tolerance test. However
Koska et al. (17) did not ﬁnd a signiﬁcant change in
plasma insulin concentration. Another study (32) exam-
ined the efﬁcacy of salsalate in reducing glycemia and
insulin resistance while attempting to deﬁne the mech-
anism of action of salsalate and validating NFBa sa
primary target in the treatment of diabetes. Further, it
was reported that during the intravenous glucose toler-
ance test there were increases in insulin and C-peptide
concentrations in patients given 4.5 g salsalate. These
observations support the hypothesis that higher doses
of salicylates effectively reduce insulin clearance
(16,32). Goldﬁne et al. (32) demonstrated that salsalate
effectively inhibits NFB activity, a well-recognized
marker of inﬂammation. These effects are thought to be
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FIG. 1. Representative sections of H&E-stained carotid arteries from uninjured (A) and injured and untreated/control (B) Zucker fatty rats. The
hyperplastic response that follows injury was signiﬁcantly reduced when the rats were treated with salsalate (C), and quantitation of the
reduction in intimal hyperplasia is depicted in D. Balloon catheter injury results in a hyperplastic response in the injured segment of the artery
and salsalate produces a signiﬁcant attenuation of the response. The reduction in intimal hyperplasia could be attributed, at least in part, to
treatment with salsalate. (A high-quality digital representation of this ﬁgure is available in the online issue.)
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necessary for the activation of NFB (15,16).
After observing the beneﬁcial effects of salsalate on the
injured vessel segment, we investigated the effect of this
agent on vascular biology in the postinjury/recovery
phase. Western blot analysis for p-eNOS and eNOS expres-
sion in vascular tissue showed an upregulation. The ex-
pression of eNOS in the salsalate-treated rats was
increased ﬁvefold compared with control rats. The p-eNOS
in rats treated with salsalate was increased 10-fold com-
pared with the control animals, showing a higher level of
p-eNOS in the salsalate-treated rats. The ratio of p-eNOS to
eNOS in the control animals was 6-to-1 (0.2/0.03) and
13-to-1 (2.0/0.15) in the rats treated with salsalate. The
upregulation of eNOS and p-eNOS would suggest that
salsalate may have a favorable effect on endothelial func-
A
VEGF staining intensity 78 ± 6 VEGF staining intensity 62 ± 7
p<0.05
Balloon injured and untreated vessels Balloon injured and salsalate treated vessels
B
FIG. 2. VEGF protein immunostained carotid artery sections of injured, untreated/control (A) and injured and treated with salsalate (B) Zucker fatty
rats. The intimal staining intensity was signiﬁcantly decreased by 22% in salsalate-treated rats (62  7) versus untreated rats (78  6). P < 0.05.
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FIG. 3. The RDUs obtained from the densitometric scan of the Western
blots of eNOS (after normalizing expression levels to corresponding
-actin) showed a marked increase in eNOS expression in aorta
samples from salsalate-treated rats when compared with the control
group. The mean relative density of scans from control rats that were
balloon catheter injured and not treated was 0.027  0.009; the mean
relative density of the salsalate-treated rats was 0.148  0.066 and was
signiﬁcantly different (P < 0.05). Compared with the control rats, the
expression of eNOS in the salsalate-treated rats was increased ﬁvefold
(0.15/0.03).
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FIG. 4. The RDUs obtained from the densitometric scan of the Western
blots for the expression of phosphorylated eNOS (ser 1177) (after
normalizing expression levels to corresponding -actin) in aortic
tissue showed an upregulation of p-eNOS by salsalate therapy. There
was a signiﬁcant difference in the mean RDU between the control and
salsalate-treated rats (0.2  0.06 vs. 2.0  0.5; P < 0.005). Compared
with the control rats, the expression of p-eNOS was increased 10-fold
(2.0/0.2). The ratio of the expression of p-eNOS to eNOS in the control
animals was 6:1 (0.2/0.03) and in the salsalate-treated rats was 13:1
(2.0/0.15).
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with previous studies (33).
In addition to changes in eNOS expression, a response
to balloon catheter injury that is often seen is the inﬂam-
matory process (27). To evaluate this component, we
assessed circulating levels of IL-6 in blood samples col-
lected at the end of the experiment. IL-6 levels were
signiﬁcantly lowered in rats treated with salsalate when
compared with levels in control rats, providing evidence in
support of the anti-inﬂammatory role of salsalate. Further,
Western blot analysis for the expression of the NFB
subunit p65 was performed. The association between
NFB and inﬂammation is well known, as it has been
shown to induce the upregulation of proinﬂammatory
cytokines and chemokines (TNF-, IL-6, IL-1, etc.) (31).
Western blot analysis for p65 in the aortic arch of the
injured, salsalate-treated rats when compared with control
rats showed a signiﬁcant decrease in expression. It is
therefore possible that treatment with salsalate sup-
pressed the activity of NFB, suggesting a mechanism for
the attenuation of the inﬂammatory response.
This study shows that VEGF expression was decreased
in the intima after treatment with salsalate, which corre-
sponds to a reduction in intimal hyperplasia. The suppres-
sion of VEGF by insulin has been shown in humans (34),
and this has been substantiated by studies in type 1
diabetics (35). The role of VEGF and its action may be
related to the pathophysiological condition.
The exercise training–associated reduction of IL-6 levels
in Zucker diabetic fatty rats has been reported by Teixeira
de Lemos et al. (36). In the present study, we also observed
a reduction of serum IL-6 in Zucker fatty rats subjected to
balloon catheter injury and treated with salsalate and may
be related to a reduction in NFB expression and vascular
inﬂammation. Oxidative stress and the generation of ROS
and their role in tissue repair are well documented. The
trauma of balloon injury and related inﬂammatory re-
sponse is a stimulus for the generation of ROS. The redox
status of the cell is maintained by antioxidant enzymes
such as superoxide dismutase, catalase, glutathione S-
transferase, and other substances such as glutathione and
vitamins E, C, and A, which help in the suppression of
ROS. MnSOD is a critical antioxidant enzyme that protects
against superoxide anion generated by normal cellular
respiration, and an inﬂammatory response was evaluated
and found to be upregulated and may be involved in the
beneﬁcial effect of salsalate (37). It is our hypothesis that
upregulation of MnSOD should decrease ROS levels. A
limitation of our study is the absence of the measurement
of ROS.
Salsalate has been shown to improve glucose and lipid
homeostasis and has been used for targeting inﬂammation
in the treatment of insulin resistance and type 2 diabetes
(32). Our data, as evidenced by a reduction in NFB p65,
increased expression of MnSOD, and a signiﬁcant reduc-
tion of intimal hyperplasia (typically seen after vascular
injury in insulin-resistant animal models) suggest that
salsalate has both anti-inﬂammatory as well as antioxida-
tive properties. It is relevant to note that insulin, the
best-known antidiabetes drug, has been reported to have a
protective effect (after vessel injury) on smooth muscle
cells and vascular endothelium resulting in the inhibition
of neointimal growth (38).
In summary, the data obtained in our study suggest that
salsalate is capable of reducing intimal hyperplasia follow-
ing balloon catheter–induced injury. It is suggested that
this effect of salsalate is due, at least in part, to its
favorable effect on endothelial eNOS/p-eNOS expression
and upregulation of anti-inﬂammatory and antioxidant
activity. The results with salsalate on intimal hyperplasia
are important and may improve our understanding of
vascular complications associated with hyperglycemia and
interventional vascular procedures.
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FIG. 5. The Western blot analysis of aortic arch NF-B subunit p65
indicated a signiﬁcant decrease expression in the salsalate-treated
group (mean relative densities of the salsalate-treated and control
groups: 0.1599  0.1092 vs. 0.6003  0.11; P  0.01). The data indicates
that salsalate treatment reduced the inﬂammatory response following
the balloon catheter injury of the carotid artery.
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FIG. 6. The MnSOD expression of aortic arch in balloon catheter
injured and untreated/control Zucker fatty rats and balloon catheter
injured and treated with salsalate. There was a signiﬁcant increase in
the mean relative density in salsalate-treated rats when compared with
control rats (control was 0.673  0.07 and salsalate 1.2  0.2; P <
0.05). The increase in the expression of this antioxidant defense
enzyme suggests that salsalate therapy enhances ROS quenching
thereby reducing tissue injury.
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